Physician profile
Amy L Suda
NPI 1942465851
$612.16
in general payments reported to CMS, 2019-2025
8 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.29 · 2022: $135 · 2023: $170 · 2024: $122 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $315.88 | 2021-2025 | Ebglyss, Taltz, Olumiant |
| Novartis Pharmaceuticals Corporation | $136.60 | 2021-2023 | |
| Regeneron Healthcare Solutions, INC. | $58.72 | 2022-2025 | Dupixent |
| Janssen Biotech, INC. | $36.24 | 2023-2025 | Tremfya |
| Genzyme Corporation | $20.86 | 2023 | |
| Abbvie INC. | $17.58 | 2022 | |
| Galderma Laboratories, L.P. | $14.78 | 2025 | Nemluvio |
| Sun Pharmaceutical Industries INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Suda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.